首页 | 本学科首页   官方微博 | 高级检索  
     

阿帕替尼多重癌1例附文献回顾
引用本文:陈丹,李加桩,隋红. 阿帕替尼多重癌1例附文献回顾[J]. 实用肿瘤学杂志, 2017, 31(5): 441-443. DOI: 10.11904/j.issn.1002-3070.2017.05.010
作者姓名:陈丹  李加桩  隋红
作者单位:天津市儿童医院(天津 300134)
摘    要:
多原发癌(Multiple primary carcinomas,MPC)又称多重癌,是指同一患者的单个或多个器官组织发生2个以上的原发癌。其中同时发现或在6个月内相继发现的多重癌为同时癌,超过6个月再发现的多重癌为异时癌。多重癌发病率低,其发病率很大程度上受放化疗的影响。多重癌在临床上容易与转移瘤相混淆,两者的治疗原则及预后有很大差异。因此及时诊治有利于提高患者生存期。现将我科收治的1例多重癌病例进行报道。

关 键 词:多重癌  卵巢癌肉瘤  阿帕替尼  
收稿时间:2017-02-16

Treatment of multiple cancer with apatinib:A case report
CHEN Dan,LI Jiazhuang,SUI Hong. Treatment of multiple cancer with apatinib:A case report[J]. Journal of Practical Oncology, 2017, 31(5): 441-443. DOI: 10.11904/j.issn.1002-3070.2017.05.010
Authors:CHEN Dan  LI Jiazhuang  SUI Hong
Affiliation:Tianjin Children's Hospital,Tianjin 300134,China
Abstract:
Multiple primary carcinomas(MPC),also known as multiple cancer,refers to single or multi-ple organ tissues occur more than two primary cancer in the same patient.In this case,it has been found multiple simultaneous cancers within 6 months.It is called metachronous cancer,which multiple cancers come from differ-ent original cancers more than 6 months.It is reported that there is a low incidence rate of multiple primary carci-nomas,which is largely influenced by radiotherapy and chemotherapy.Multiple primary cancers are easy to be confused with metastatic tumors in clinical practice,both of them are quite different in terms of treatment and prognosis.Therefore,it is helpful to improve the survival of patients by timely diagnosis and treatment.This article reported a case of multiple primary carcinomas.
Keywords:Multiple primary carcinomas  Ovarian carcinosroma  Apatinib
本文献已被 万方数据 等数据库收录!
点击此处可从《实用肿瘤学杂志》浏览原始摘要信息
点击此处可从《实用肿瘤学杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号